Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05693701 · ClinicalTrials.gov registry record · NA

Multicomponent Intervention Study- Blood Donors With High Cholesterol

A NA study of Lipid Metabolism Disorder, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05693701 is a NA study of Lipid Metabolism Disorder that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05693701, a NA study of Lipid Metabolism Disorder, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).

Conditions Studied

Interventions

  • BEHAVIORAL Implementation Strategy Bundle
  • OTHER Usual care notification

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-02-27
Est. Completion 2027-04-30
Phase NA

What the Registry Record Tells You About NCT05693701

The ClinicalTrials.gov registry entry for NCT05693701 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lipid Metabolism Disorder appearing as the primary indexed condition, and to 2 interventions - of which Implementation Strategy Bundle is the first listed.

NCT05693701 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05693701 about?

NCT05693701 is a clinical study titled "Multicomponent Intervention Study- Blood Donors With High Cholesterol". The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).

What is the current status of trial NCT05693701?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-02-27. Estimated completion is 2027-04-30.

What conditions does trial NCT05693701 study?

This clinical trial studies the following conditions: Lipid Metabolism Disorder.

What interventions are being tested in trial NCT05693701?

The interventions under investigation include: Implementation Strategy Bundle (BEHAVIORAL), Usual care notification (OTHER).

Who is sponsoring clinical trial NCT05693701?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05693701 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lipid Metabolism Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.